Recruiting COPD Studies in Baltimore
Multi-Center Clean Air Randomized Controlled Trial in COPD
This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk...
Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)
The purpose of this study is to determine if doxycycline will reduce progression of emphysema in people living with HIV. The secondary objectives are to examine the effects of doxycycline on change i...
About COPD Clinical Trials in Baltimore
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes breathing difficult, primarily caused by smoking. It includes emphysema and chronic bronchitis. Treatment involves bronchodilators, inhaled steroids, pulmonary rehabilitation, and oxygen therapy.
There are currently 2 copd clinical trials recruiting participants in Baltimore, MARYLAND. These studies are seeking a combined 1,020 participants. Research is being sponsored by JHSPH Center for Clinical Trials, Weill Medical College of Cornell University. Clinical trial participation is free and participants receive study-related medical care at no cost.
COPD Clinical Trials in Baltimore — FAQ
Are there copd clinical trials in Baltimore?
Yes, there are 2 copd clinical trials currently recruiting in Baltimore, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What copd treatments are being tested?
The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for copd.
Data updated March 2, 2026 from ClinicalTrials.gov